Keith M. Sieracki, PA-C

Keith Sieracki practices at Heart Specialists of Sarasota PL in Sarasota, Florida.

Keith Sieracki's NPI, 1760436232, was assigned on May 20, 2006.

Keith Sieracki's primary practice is Heart Specialists of Sarasota PL, at 1950 Arlington St, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 917-4250.

Keith Sieracki's primary practice is Heart Specialists of Sarasota PL in Sarasota, Florida. Keith Sieracki is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Heart Specialists of Sarasota. Dmand AI also links Keith Sieracki to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Keith Sieracki practices, 4 sites in all. Vendor and product names are available with a free account.

Medical is Keith Sieracki's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Keith Sieracki is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA).

Dmand AI lists acute mini-stroke (TIA), arthritis, asthma, chronic obstructive pulmonary disease (COPD), sleep apnea and tobacco use among the conditions Keith Sieracki treats.

CMS data shows 3,583 Medicare services from Keith Sieracki across 9 procedure codes in 2024, for 1,742 Medicare patients. Medicare paid $204,179 for them.

CMS counts 1,742 Medicare patients who saw Keith Sieracki in 2024. The largest group is 75 to 84, with 836 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Keith Sieracki's median patient age at 79, with 46% women.

In 2024, Keith Sieracki wrote 2,595 Medicare Part D claims for 747 patients. 77% of them were for generic drugs. CMS names the drug for 2,447 of them, across 39 drugs with 11 or more claims each, at $547,645 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Keith Sieracki for performance year 2024, reported as part of a group. Keith Sieracki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Keith Sieracki as offering telehealth.

CMS Open Payments shows 153 general payments to Keith Sieracki from 20 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $639.

Keith Sieracki is a member of AAPA and ACC.